108 related articles for article (PubMed ID: 26265556)
1. Evaluating sirolimus-based immunosuppression for the prevention of cytomegalovirus replication after liver transplantation.
Arasaratnam RJ
Clin Transplant; 2015 Sep; 29(9):723. PubMed ID: 26265556
[No Abstract] [Full Text] [Related]
2. The effect of sirolimus-based immunosuppression vs. conventional prophylaxis therapy on cytomegalovirus infection after liver transplantation.
Sheng L; Jun S; Jianfeng L; Lianghui G
Clin Transplant; 2015 Jun; 29(6):555-9. PubMed ID: 25851741
[TBL] [Abstract][Full Text] [Related]
3. Cytomegalovirus infection after liver transplantation using different prophylaxes.
Kornberg A; Grube T; Hommann M; Schotte U; Scheele J
Transplant Proc; 2001; 33(7-8):3624-5. PubMed ID: 11750539
[No Abstract] [Full Text] [Related]
4. Prevention of cytomegalovirus disease after heart transplantation: preemptive therapy with 7 days' intravenous ganciclovir.
Paniagua MJ; Crespo-Leiro MG; De la Fuente L; Tabuyo T; Mosquera I; Cañizares A; Naya C; Fariña P; Juffé A; Castro-Beiras A
Transplant Proc; 2002 Feb; 34(1):69-70. PubMed ID: 11959189
[No Abstract] [Full Text] [Related]
5. Ganciclovir prophylaxis of cytomegalovirus disease.
Conti DJ; Shen G; Singh T; Isenberg A; Freed BM
Transplant Proc; 1997; 29(1-2):804-6. PubMed ID: 9123534
[No Abstract] [Full Text] [Related]
6. Prophylaxis of cytomegalovirus disease with intravenous ganciclovir in renal transplantation.
Sancho A; Górriz JL; Crespo JF; Avila A; Alcaraz MJ; García Ramos JL; Pallardó LM
Transplant Proc; 1999 Sep; 31(6):2337-8. PubMed ID: 10500606
[No Abstract] [Full Text] [Related]
7. Preemptive ganciclovir therapy in renal transplantation.
Brennan DC; Storch GA; Lippman BJ
Ann Intern Med; 1996 Apr; 124(7):693. PubMed ID: 8607602
[No Abstract] [Full Text] [Related]
8. [The prevention and treatment of cytomegalovirus infection after liver transplantation].
Zheng SS; Jiang ZJ; Xu X; Liang TB; Wang WL; Shen Y; Zhang M; Lu AW
Zhonghua Wai Ke Za Zhi; 2005 May; 43(9):584-6. PubMed ID: 15938930
[TBL] [Abstract][Full Text] [Related]
9. Management of cytomegalovirus infection after liver transplantation.
Sampathkumar P; Paya CV
Liver Transpl; 2000 Mar; 6(2):144-56. PubMed ID: 10719012
[No Abstract] [Full Text] [Related]
10. Prevention of cytomegalovirus disease in transplant recipients.
Winston DJ
Lancet; 1995 Nov; 346(8987):1380-1. PubMed ID: 7475816
[No Abstract] [Full Text] [Related]
11. Cytomegalovirus prophylaxis with ganciclovir in kidney transplant recipients receiving induction antilymphocyte antibodies.
Said T; Nampoory MR; Johny KV; Pacsa AS; Mini Abraham P; Nair MP; Abdel-Haleem M; Samhan M; Al-Mousawi M
Transplant Proc; 2004; 36(6):1847-9. PubMed ID: 15350495
[TBL] [Abstract][Full Text] [Related]
12. Cost analysis of four strategies for prevention of CMV infection in liver transplant recipients.
Post AB; Mulligan DC; Bush W
Transplant Proc; 1998 Aug; 30(5):2102-3. PubMed ID: 9723406
[No Abstract] [Full Text] [Related]
13. Prevention of cytomegalovirus following solid organ transplantation: a literature review.
Kowalsky S; Arnon R; Posada R
Pediatr Transplant; 2013 Sep; 17(6):499-509. PubMed ID: 23890075
[TBL] [Abstract][Full Text] [Related]
14. Incidence and therapy of cytomegalovirus disease after liver transplantation.
Wiens M; Lefèbre B; Blumhardt G; Schmidt CA; Lohmann R; Neuhaus P
Transplant Proc; 1993 Apr; 25(2):1985-6. PubMed ID: 8385829
[No Abstract] [Full Text] [Related]
15. Preemptive therapy for cytomegalovirus with oral ganciclovir after liver transplantation.
Singh N
Transplantation; 2002 Jun; 73(12):1977; author reply 1977-8. PubMed ID: 12131704
[No Abstract] [Full Text] [Related]
16. Viral prophylaxis in hepatic transplantation: preliminary report of a randomized trial of acyclovir and gancyclovir.
Nakazato PZ; Burns W; Moore P; Garcia-Kennedy R; Cox K; Esquivel C
Transplant Proc; 1993 Apr; 25(2):1935-7. PubMed ID: 7682357
[No Abstract] [Full Text] [Related]
17. Prophylaxis of cytomegalovirus primary infection with short-term ganciclovir therapy.
Lauzurica R; Bayés B; Frías C; Hernández A; Jimenez A; Fontseré N; Romero R
Transplant Proc; 2003 Aug; 35(5):1751-2. PubMed ID: 12962781
[No Abstract] [Full Text] [Related]
18. Ganciclovir-resistant cytomegalovirus.
Legendre C
Lancet; 2000 Oct; 356(9238):1356. PubMed ID: 11073050
[No Abstract] [Full Text] [Related]
19. Improved survival with cytomegalovirus infection after intestinal transplantation in children.
Bueno J; Green M; Reyes J; Jabbour N; Kocoshis S; Yunis E; Todo S; Starzl TE
Transplant Proc; 1996 Oct; 28(5):2770-1. PubMed ID: 8908050
[No Abstract] [Full Text] [Related]
20. [Effectiveness of preemptive therapy with ganciclovir in recipients of renal transplants at high risk (R-/D+) for the development of cytomegalovirus disease].
Aranda-Verástegui F; Alberú J; Soto-Ramírez LE; González-Aguirre H; Muñoz Trejo T; Mancilla E; Díliz H; Correa-Rotter R; Sierra-Madero J
Rev Invest Clin; 2002; 54(3):198-203. PubMed ID: 12183888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
